Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible SensitivityCancer of Gastrointestinal Tract, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genitourinary Cancer, Head and Neck Neoplasms, Male Urogenital Diseases, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Neoplasms, Unknown Primary, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Unknown Primary Tumors, Urogenital Diseases, Urogenital Neoplasms, breast cancer, breast disorder, breast neoplasm, digestive system disorder, digestive system neoplasm, female reproductive organ cancer, head and neck cancer, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, sarcoma, skin disorder, skin neoplasmRecruitingPhase 22026-09-16NCT04273061

5 results · Page 1 of 1

Swipe the table sideways for more columns.

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
BC CancerVancouverCanada9
University Health Network / Princess Margaret Cancer CentreTorontoCanada1